Examination about the change of the cerebral blood flow before and after the treatment of the abstinence supplement using the cerebral blood flow scintigraphy

Not Applicable

• Conditions: Alcoholism

• Registration Number: JPRN-UMIN000011144
• Lead Sponsor: Osaka City University, Graduate School of MedicineDepartment of Nuclear Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-08-01
• Study Completion: 2015-12-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

The patients who drank again during abstinence from alcoholic drinks treatment. The patients who stopped going to hospital and treatment by oneself. The patients who were not able to undergo cerebral blood flow scintigraphy.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
In this study, we intend for the patients who consulted an alcohol dependence treatment outpatient. We intend for the patients with the abstinence will. We use Regtect as abstinence adjuvant medicine. Treatment using Regtect is provided. We conduct a cognitive function evaluation and foreign follow-up before and after treatment. The cerebral blood flow scintigraphy is carried out in a hospital nuclear medicine laboratory attached to the Osaka City University School of Medicine.